Skip to search formSkip to main contentSkip to account menu

Technetium Tc 99m Pentetate

Known as: 99m-DTPA, Tc, Tc 99m DTPA, Technetium (99m) Pentetate 
A radiopharmaceutical core of chelating agent DTPA (diethylenetriaminepentaacetic acid) complexed with the gamma-emitting radionuclide technetium Tc… 
National Institutes of Health

Related topics

Related topics

14 relations

Broader (2)

Chelating AgentsRadiopharmaceuticals
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Narrower (5)

technetium Tc 99m DTPA-galactosyl-human serum albumintechnetium Tc 99m methoxypoly(ethylene)glycol-polylysyl-DTPAtechnetium Tc 99m methoxypolyethylene glycol-polylysyl-DTPA monoamidetechnetium Tc 99m polydiethylenetriamine pentaacetic acid polymannosyl polylysine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.
Highly Cited
2007
Highly Cited
2007
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Nanometer-sized colloidal particles (nanoparticles) have been extensively used in biomedical applications as a result of their… 
Highly Cited
2001
Highly Cited
2001
Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques
Background—Molecular imaging of thrombus within fissures of vulnerable atherosclerotic plaques requires sensitive detection of a… 
Highly Cited
1999
Highly Cited
1999
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma.
PURPOSE Yttrium-90 ibritumomab tiuxetan (IDEC-Y2B8) is a murine immunoglobulin G1 kappa monoclonal antibody that covalently binds… 
Review
1997
Review
1997
Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging
  • P. Tofts
  • Journal of Magnetic Resonance Imaging
  • 1997
  • Corpus ID: 3026177
Three major models (from Tofts, Larsson, and Brix) for collecting and analyzing dynamic MRI gadolinium‐diethylenetriamine penta… 
Highly Cited
1996
Highly Cited
1996
Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.
BACKGROUND Contrast medium-enhanced magnetic resonance images of acute, reperfused infarcts have shown hypoenhanced and… 
Highly Cited
1991
Highly Cited
1991
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
Dynamic MR imaging can be used to study tissue perfusion and vascular permeability. In the present article a procedure for… 
Highly Cited
1989
Highly Cited
1989
MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations.
Of a total of 191 magnetic resonance breast studies performed since March 1984, 82 were performed with gradient-echo fast low… 
Highly Cited
1984
Highly Cited
1984
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.
Chelation of the rare-earth element gadolinium (Gd) with diethylenetriaminepentaacetic acid (DTPA) results in a strongly… 
Highly Cited
1980
Highly Cited
1980
INCREASED ALVEOLAR EPITHELIAL PERMEABILITY IN CIGARETTE SMOKERS
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)